Placenta Accreta Clinical Trial
Official title:
Bladder Filling in Cesarean Hysterectomy for Placenta Percreta: A Randomized Trial
The placenta accreta spectrum (PAS) which includes accreta, increta, and percreta represents
a significant obstetric challenge. PAS complicates as many as 1 per 500 pregnancies and this
risk is increased with prior cesarean deliveries. Antenatal diagnosis of PAS allows for
multidisciplinary planning and delivery before the onset of labor and/or vaginal bleeding.
This approach has reduced maternal morbidity rates. including less blood loss, fewer
transfusion requirements and, intraoperative urinary tract injury as well as improve fetal
outcome.
Ultrasound evaluation is the recommended first-line modality for diagnosing PAS. Ultrasound
features suggestive of PAS include loss of the normal retroplacental clear zone, attenuation
of the uterine-bladder interface, reduced retroplacental myometrial thickness, presence of
intraplacental lacunar spaces, and bridging vessels between the placenta and bladder. A
systematic review reported that the antenatal diagnosis of PAS significantly lowered the rate
of urinary tract injury (from 63% to 39%) during cesarean hysterectomies in these cases.
Unlike other elective cesarean hysterectomies, cesarean hysterectomy with a placenta previa
increta/percreta, is more difficult. There is a greater need to both keep a margin from the
vascular cervical-placental mass and simultaneously protect the urinary bladder. Case series
reported that bladder filling helps the surgeon to more clearly identify the planes of
dissection and secure the engorged aberrant vessels, thereby reduces bladder injury.
Accordingly, a prospective randomized study in pregnant patients with placenta previa
increta/percreta undergoing elective cesarean hysterectomy will be conducted to address this
important issue.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04579172 -
Conservative Management of Morbidly Adherent Anterior Situated Placenta
|
N/A | |
Completed |
NCT04593303 -
Internal Iliac Artery Ligation During Management of Placenta Accreta Spectrum
|
N/A | |
Recruiting |
NCT03638024 -
Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
|
||
Not yet recruiting |
NCT06100640 -
Paracervical Pouch in Placenta Accreta Spectrum
|
||
Completed |
NCT05979181 -
Peripartum Cesarean Hysterectomy for Placenta Percreta
|
||
Recruiting |
NCT04609527 -
Management of Placenta Accreta Spectrum
|
Phase 2/Phase 3 | |
Recruiting |
NCT06185894 -
Single-step Placenta Accreta Resective Technique Tourniqueted vs Absence, Conservative Uterine Surgery
|
N/A | |
Completed |
NCT04573452 -
Galectin-3 and Placenta Accreta
|
||
Not yet recruiting |
NCT03273569 -
PDIUC Protocol for Placental Accreta
|
N/A | |
Completed |
NCT03707132 -
Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta
|
||
Not yet recruiting |
NCT05104177 -
Effectivness of Conservative Techniques in Management of PAS
|
||
Completed |
NCT02806024 -
Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study
|
Phase 4 | |
Active, not recruiting |
NCT02784886 -
Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta
|
N/A | |
Recruiting |
NCT05070689 -
Placenta Accreta Spectrum Disorders: A. Chohan Continuous Squeezing Suture (ACCSS)
|
N/A | |
Completed |
NCT05813743 -
Detection of Urinary Bladder Wall Involvement in Abnormally Invasive Placenta (AIP) by 3D Ultrasonography
|
N/A | |
Withdrawn |
NCT04003428 -
Feasibility of HIFU for Management of Placenta Accreta (HIFU-ACCRETA)
|
N/A | |
Completed |
NCT04161521 -
Conservative Surgical Novel Technique of Placenta Accreta in Menoufia University Hospital
|
N/A | |
Recruiting |
NCT05139498 -
Conservative Management for PAS Pilot
|
N/A | |
Not yet recruiting |
NCT03530475 -
Diagnostic Accuracy of Doppler Ultrasound and Role of Uterine Artery Doppler
|
N/A | |
Recruiting |
NCT05922397 -
Placenta Accreta Spectrum Topographic Classification
|